|
Why the CSRO Conference Matters for Fellow Rheumatologists
By Michael Vempala, MD
Rheumatology Fellow (PGY-5)
VT Carilion Rheumatology Fellowship
My experience at the Coalition of State Rheumatology Organizations (CSRO) Fellows Conference was both eye-opening and highly relevant to the realities of modern rheumatology practice. As the only fellow from my cohort to attend this year, I had a unique opportunity to engage with peers and mentors on topics that are often set aside during clinical training. While fellowship emphasizes mastering the diagnosis and treatment of complex autoimmune diseases, it can overlook the logistical and systemic barriers that frequently prevent patients from accessing care. The CSRO conference addressed these challenges directly in a way that was both practical and accessible for fellows and early-career rheumatologists.
One of the most valuable aspects of the meeting was the opportunity to connect with rheumatology fellows from across the country. Despite differences in geography and practice settings, it became clear that many of us face the same challenges. Obstacles such as step therapy requirements, prior authorization delays, restrictive formularies, and “underwater medications”—where reimbursement does not cover the cost of providing treatment—were recurring themes. These shared experiences reinforced that these are not isolated issues, but widespread barriers impacting patient care nationwide.
What makes the CSRO conference particularly impactful is its focus on addressing these challenges in a practical and actionable way. Beyond identifying the problems, the conference emphasized education, collaboration, and advocacy. Fellows were introduced to ongoing legislative and policy efforts led by state rheumatology societies to improve access to care and reduce administrative burden. These sessions provided valuable insight into how healthcare policy is shaped and highlighted the important role physicians can play in influencing change. We also learned about opportunities to engage directly in advocacy, including organized meetings with lawmakers.
Equally important was the sense of community fostered throughout the conference. Engaging with fellows from across the country created a space to exchange ideas, discuss strategies for navigating common challenges, and learn from one another’s experiences. This peer-to-peer learning complemented the formal sessions and underscored the value of collaboration within our field.
For fellows approaching independent practice, this exposure is invaluable. While clinical training prepares us to manage disease, it does not always equip us to navigate insurance systems, medication access issues, and the broader healthcare landscape. The CSRO conference helps bridge that gap by providing a framework for understanding these complexities and offering tools to address them effectively. It reinforces that being an effective rheumatologist today requires engagement beyond the clinic, including participation in advocacy and policy efforts.
Ultimately, the CSRO conference serves as a reminder that patient care extends far beyond diagnosis and treatment decisions. Ensuring timely access to appropriate therapies is often influenced by factors outside of direct clinical control. For fellows and trainees, involvement in forums like CSRO is not only beneficial—it is essential. I strongly encourage fellow trainees to take advantage of these opportunities and to become actively engaged in shaping the future of our field.
| 
